Journal of Postgraduate Medicine, Education and Research

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  58 (2024)
Volume  57 (2023)
Volume  56 (2022)
Volume  55 (2021)
Volume  54 (2020)
Volume  53 (2019)
Volume  52 (2018)
Volume  51 (2017)
Volume  50 (2016)
Volume  49 (2015)
Volume  48 (2014)
Volume  47 (2013)
Volume  46 (2012)
Related articles

VOLUME 47 , ISSUE 4 ( October-December, 2013 ) > List of Articles

REVIEW ARTICLE

Tuberculosis of Central Nervous System

Manish Modi, Abhishek Garg

Citation Information : Modi M, Garg A. Tuberculosis of Central Nervous System. J Postgrad Med Edu Res 2013; 47 (4):202-213.

DOI: 10.5005/jp-journals-10028-1086

Published Online: 01-09-2015

Copyright Statement:  Copyright © 2013; The Author(s).


Abstract

How to cite this article

Modi M, Garg A. Tuberculosis of Central Nervous System. J Postgrad Med Edu Res 2013;47(4):202-213.

PDF Share
  1. Frequently asked questions about TB and HIV. 2010. Available at: http://www.who.int/tb/challenges/hiv/faq/en/index.html. Accessed 2010.
  2. Tuberculosis in the United States. Am J Epidemiol 1979;109:205-209.
  3. A prospective study the risk of tuberculosis among intravenous drug abusers with human immunodeficiency syndrome and its related complex. Ann Intern Med 1986;320:345-350.
  4. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO surveillance and monitoring project. JAMA 1999;282:677-686.
  5. Tuberculosis of the central nervous system. Postgrad Med J 1999;75:133-140.
  6. Tuberculosis. In: Scheld WM, Whitley RJ, Marra CM, editors. Infection of the central nervous system, 3rd edition. Lippincot Williams and Williams 2004;441-460.
  7. Tuberculous Meningitis. J Neurol Neurosurg Psychiatry 2000;68:289-299.
  8. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med 1990;322:122-127.
  9. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Eng J Med 1998;338:640-644.
  10. Mycobacterium tuberculosis molecular variation in CNS infection: Evidence for strain-dependent neurovirulence. Neurology 1998;50:1827-1832.
  11. Deciphering the biology of Mycobacterium tuberculosis from the complete genomic sequence. Nature 1998;393:537-544.
  12. Tuberculous encephalopathy with and without meningitis: Clinical features and pathological correlation. J Neurol Sci 1970;10:541-561.
  13. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989;56:731-740.
  14. Effect of mycobacteria on sensitivity to the cytotoxic effects of tumor necrosis factor. Infect Immunol 1991;59:2567-2572.
  15. A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis associated death. J Inf Dis 1998;177:1563-1572.
  16. Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc Natl Acd Sci 1999;96:5657-5662.
  17. Concentrations of interferon gamma, tumor necrosis factor alpha, and interleukin-1 beta in the cerebrospinal fluid of children treated for tuberculous meningitis. Clin Infect Dis 1995;21:924-929.
  18. Cerebrospinal fluid cytokines in patients with tuberculous meningitis. Clin Immnol Immnopathol 1997;84:171-176.
  19. Nitric oxide, TNF-alpha, and IL-8 in cerebrospinal fluids of Tuberculous and Cryptococcus meningitis. Hunan Yi Ke Xue Xue Bao 1997;22:514-516.
  20. Matrix metalloproteinases contribution to the blood-brain-barrier disruption during bacterial meningitis. Ann Neurol 1998;44:592-600.
  21. Matrix metalloproteinase MMP-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: Association with blood brain-barrier damage and neurological sequelae. Clin Infect Dis 2000;31:80-84.
  22. Pathogensis of tubercular meningitis. Bulletin of John Hopkins Hospital 1933;52:5-13.
  23. Pathology and pathogenetic mechanisms in Neurotuberculosis. Radiol Clin North Am 1995;33:733-752.
  24. Locations of cerebral infarctions in tubercular meningitis. Neuroradiology 1992;34:197-199.
  25. Tuberculous meningitis in Cleveland Metropoliton General Hospital 1959 to 1963. Am Rev Resp Dis 1967;95:670–673.
  26. CNS tuberculosis. Neurology India 1997;45(3):132-140.
  27. Streptomycin treatment of tuberculous meningitis. Lancet 1948;i:582-596.
  28. Tuberculous meningitis. J Am Med Asso 1979;241:264-268.
  29. Chloride levels in meningitis. S Afr Med J 1998;73:522-523.
  30. Tuberculous meningitis-A clinical study of 232 cases. J Assoc Phy Ind 1977;25:1-7.
  31. Pathogenesis, diagnosis, treatment and outcome aspects of CNS Tuberculosis. Med Sci Monit 2004;19(9) RA: 215-229.
  32. Correlation between isolation of M. tuberculosis and estimation of mycobacterial antigen in cisternal, ventricular and lumbar CSF in patients with tuberculous meningitis. Ind J Pathol Microbiol 1993;36:341-347.
  33. The genus Mycobacterium. In: Emmerson AM, Hawkey PM, Gillespie SH, editors. Principles and practice of clinical bacteriology, Chichester: John Wiley 1997:121-146.
  34. Tuberculostearic acid as a diagnostic marker in tuberculous meningitis. Lancet 1983;ii:367-371.
  35. Rapid diagnosis of tuberculous meningitis by frequency pulsed electron-capture gas liquid chromatography detection of carboxylic acid in cerebrospinal fluid. J Clin Microbiol 1990;28:989-997.
  36. Adenosine deaminase in cerebrospinal fluid for the diagnosis and follow up of tuberculous meningitis in adults. J Infec Dis 1987;155:603-607.
  37. The enzyme linked immnosorbent assay method for IgG to purified protein derivative in cerebrospinal fluid of patients with tuberculous meningitis. Ann Int Med 1983;99:630-633.
  38. The potential contribution of polymerase chain reaction to the diagnosis of tuberculous meningitis. Arch Neurol 1996;53:771-776.
  39. Molecular typing of mycobacterial tuberculosis isolates from different parts of India based on IS6110 element polymorphism using RFLP analysis. Indian J Med Res 2007;125:577-581.
  40. Multiplex PCR for rapid diagnosis of tuberculous meningitis. J Neurol 2011;258:1781-1787.
  41. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363:1005-1015.
  42. Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur Radiol 2003;13:1876-1890.
  43. Value of CT scan in the diagnosis of meningitis. Indian Pediatr 1996; 33:465-468.
  44. MR Imaging of central nervous system tuberculosis. Radiol Clin North Am 1995;33(4):771-786.
  45. Neurological and related syndromes in CNS tuberculosis: Clinical features and pathogenesis. J Neurol Sci 1971;14:341-349.
  46. Intracranial tuberculomas developing while on therapy for pulmonary tuberculosis. Lancet Infect Dis 2005;5:795-801.
  47. Pathological analysis of intracranial space occupying lesions in 1000 cases including children. J Neurol Sci 1968;6:575-592.
  48. A comparative study of brain tuberculomas and gliomas based upon 107 case records of each. Brain 1965; 88:375-396.
  49. Intracranial tuberculoma and CT scan. J Neurosurg 1988;64: 568-574.
  50. CT of intracranial tuberculomas with special reference to the target sign. Neuroradiology 1988;30:329
  51. Intracranial tuberculomas: MRI signal correlation with histopathology and localized proton MR Spectroscopy. Mag Reson Imag 1991;2:443-449.
  52. MRI: More specific than CT in cranial tuberculomas. Neuroradiology 1991;33(4):216-218.
  53. Proton MR spectroscopy of the brain. Seminars in Ultrasound and CT and MRI 2000;21(6):434-451.
  54. Comparative evaluation of magnetization transfer MR imaging and in vivo proton MR spectroscopy in brain tuberculomas. Magnetic Resonance Imaging 2002;20:375-381.
  55. Differentiating solitary small cysticercous graulomas and tuberculomas in patients with epilepsy: clinical and computed tomographic criteria. J Neurosurg 1993;78:402-407.
  56. Effect of medical treatment in intracranial tuberculoma: a CT study. Tubercle 1985;66:85
  57. Paradoxial enlargement or development of intracranial tuberculomas during therapy: Case report and review. Clinic Inf Dis 1994;19:1092-1099.
  58. Symptomatic intracranial tuberculoma developing during treatment of tuberculosis. A report of 10 patients and review of literature. Q J Med 1987;63:449-460.
  59. Tuberculous brain abscess in patient with HIV infection: Case report and review. Am J Med 1997;102:297-301.
  60. Cerebrospinal fluid isoniazid concentrations in children with tuberculous meningitis: The influence of dosage and acetylation status. Paediatrics 1992;89:247-250.
  61. Cerebrospinal fluid drug concentration and the treatment of tuberculous meningitis. Am Rev Resp Dis 1993;148;650-655.
  62. Intensive short course chemotherapy in the management of Tuberculous meningitis. Int J Tub Lung Ds 1998;2:704-711.
  63. The management of Tuberculous meningitis. Thorax 1992;47:577-581.
  64. Streptomycin: absorption, diffusion, exertion and toxicity. Am J Med Sci 1945;210:567-582.
  65. Am J Respir Crit Care Med 2003;167:603-662.
  66. Whither short-course chemotherapy for tuberculosis meningitis. Neurosurgery 1990;27:418-421.
  67. Short term antimicrobial therapy in tuberculous meningitis. Am Rev Respir Dis 1960;82:672-681.
  68. Treatment of tuberculous meningitis: Role of short-course chemotherapy. Q J Med 1987;62:249-258.
  69. The treatment of Tuberculous meningitis. Tubercle 1989;70:79-82.
  70. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: An open-label, randomised controlled phase 2 trial. Lancet Infect Dis 2013 Jan;13(1):27-35.
  71. Directly observed treatment, short course in tuberculous meningitis: Indian perspective. Ann Indian Acad Neurol 2013 Jan;16(1):82-84.
  72. Management of intracranial pressure in tuberculous meningitis Neurocrit care 2005;2:306-312.
  73. Effect of corticosteroids on intracranial pressure, computed tomographic findings and clinical outcome in young children with tuberculous meningitis. Paediatrics 1997;99:226-231.
  74. Dexamethasone for the treatment of Tuberculous meningitis in adolescents and adults. N Engl J Med 2004;351(17):1741-1751.
  75. Corticosteroids for managing tuberculous meningitis. Cochrane Database of Systematic Reviews 2008;(1):CD002244.
  76. Effect of steroids on cerebrospinal fluid penetration of antituberculous drugs in tuberculous meningitis. Clin Pharmacol Tacr 1991;49:6-12.
  77. Carmicheal A, Lever AM. The use of thalidomide in the treatment of intracarnial tuberculomas in adults: two case reports. J Infection 2003;47:251-255.
  78. Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study. J Child Neurol 2004;19:250-257.
  79. The influence of HIV infection on clinical presentation, response to treatment, and ourtcome in adults with TBM. J Inf dis 2005;192:2134-2141.
  80. Tuberculous meningitis in HIV infected individuals. Curr HIV/AIDS Rep 2009;6(3):139-145.
  81. Shunt surgery for hydrocephalus in tubercular meningitis: A long term follow-up study. J Neurosurg 1991;74:64-69.
  82. Multiple intracranial tuberculomas with atypical response to chemotherapy: Literature review and a case report. Infection 1997;25:233-239.
  83. Brain abscess and its surgical management. Surg Neurol 1982;18:7-17.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.